Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Fear Extinction Via Angiotensin Type 1 Receptor Inhibition: A Randomized Controlled Trial in Posttraumatic Stress Disorder

NCT02709018 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT02709018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02709018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Fear Extinction Via Angiotensin Type 1 Receptor Inhibition: A Randomized Controlled Trial in Posttraumatic Stress Disorder
Lead sponsor
University of California, San Diego
Phase
Not applicable
Overall status
Completed
Start date
July 16, 2016
Completion date
September 29, 2020
Enrollment
149 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

posttraumatic stress disorder